The proposed bill, known as the 340B Contract Pharmacy Protection Act, aims to enhance protections for entities participating in the 340B drug pricing program in Nebraska. It establishes definitions for key terms such as "340B drug" and "340B entity," and prohibits manufacturers and their affiliates from denying or restricting the acquisition and delivery of 340B drugs to authorized locations. Additionally, it prevents these entities from requiring 340B entities to submit various types of data as a condition for drug acquisition, unless mandated by federal law.

The bill empowers the Attorney General or county attorneys to take legal action against violations of the Act and includes a severability clause to ensure that if any part of the Act is deemed invalid, the remaining provisions will still be enforceable. Furthermore, it clarifies that the Act will not conflict with federal law or other compatible state laws. Due to the urgency of the matter, the Act is set to take effect immediately upon passage and approval.